Virtu Financial’s Tourmaline Bio TRML Stock Holding History

Virtu Financial’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26,273	Closed	-$1.26M	–	2243
2025 Q3	$1.26M	Buy	+26,273	New	+$729K	0.07%	272
2023 Q1	–	Sell	-1,637	Closed	-$17K	–	2106
2022 Q4	$17K	Buy	+1,637	New	+$26.3K	﹤0.01%	1298
2022 Q3	–	Sell	-1,240	Closed	-$56K	–	2246
2022 Q2	$56K	Buy	+1,240	New	+$97.8K	﹤0.01%	1094

Virtu Financial's TRML Position: Q4 2025 in Review

Virtu Financial sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 26,273 shares — an estimated $1.26M sold.

Virtu Financial first reported a position in TRML in Q2 2022 and held it in 3 quarters. The position peaked at $1.26M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Virtu Financial reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 26,273 Tourmaline Bio shares in Q4 2025, an estimated $1.26M.
Virtu Financial first reported a position in Tourmaline Bio in Q2 2022 and held it in 3 quarters.
Virtu Financial's Tourmaline Bio position peaked at $1.26M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.